Last reviewed · How we verify
NCT05633316: ICSIA
Automated Intracytoplasmic Sperm Injection (ICSIA)
NA trial testing Investigational device named ICSIA in Infertility, Female in 10 participants. Status unknown.
30 November 2023
Quick facts
| Lead sponsor | Overture Life |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 5 December 2022 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Investigational device named ICSIA
- Manual ICSI
Conditions studied
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Overture Life
Who can join
Adults 18 to 50, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to evaluate Overture's automated Intracytoplasmic Sperm Injection (ICSIA) System. ICSIA is an investigational medical device that automates injection of sperm into eggs. This study will evaluate survival and fertilization rates of oocytes handled via ICSIA and compare to survival and fertilization rates of oocytes which are manually injected with sperm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05633316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility, Female
Currently open trials in the same condition.
- NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
- NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
- NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
Other Overture Life trials
Trials by the same sponsor.
- NCT06853418 — Paired Non-inferiority Study Comparing Overture Semi-automated Vitrification System ("DaVitri") to Standard Manual Proce · NA · recruiting
- NCT05607771 — DaVitri: Semi-Automated Vitrificacion Clinical Study · NA · unknown
- NCT04976920 — Metabolomics Non Selection Study - Vitrolife Media · unknown
- NCT04878991 — Overture Metabolomics Non-Selection Study · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05633316 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Overture Life
- Last refreshed: 6 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05633316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing